Breithorn Capital Management’s Gilead Sciences GILD Stock Holding History

Breithorn Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$4.68M	Buy	+66,090	New	+$4.4M	3.31%	16

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Breithorn Capital Management's GILD Position: Q2 2017 in Review

Breithorn Capital Management opened a new position in Gilead Sciences (GILD) in Q2 2017: 66,090 shares worth $4.68M. The stake represents 3.31% of the portfolio and ranks #16 among its holdings.

1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

Breithorn Capital Management held 66,090 shares of Gilead Sciences worth $4.68M as of Q2 2017.
Gilead Sciences was a new Breithorn Capital Management position in Q2 2017.
Gilead Sciences made up 3.31% of Breithorn Capital Management's portfolio in Q2 2017, its #16 holding.
1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Breithorn Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.